United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read General business news Blackstone beats earnings estimates, CEO foresees broad-based acceleration Blackstone Inc., the world’s leading alternative asset manager, reported stellar third-quarter results for fiscal year 2024-2025, exceeding Wall… byPallavi MadhirajuOctober 17, 2024